ACIU
AC Immune SA
$2.53
+$0.08(+3.27%)
36
Overall
--
Value
36
Tech
--
Quality
Market Cap
$255.04M
Volume
60.79K
52W Range
$1.43 - $3.98
Target Price
$9.00
Order:
Income Statement
| Metric | Trend | Chart | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|
| REVENUE | |||||
| Total Revenue | $3.9M | $14.8M | $27.3M | ||
| Total Revenue | $3.9M | $14.8M | $27.3M | ||
| COST OF GOODS SOLD | |||||
| Cost of Revenue | $-74.8M | -- | -- | ||
| GROSS PROFIT | |||||
| Gross Profit | $3.9M | $14.8M | $27.3M | ||
| OPERATING EXPENSES | |||||
| Operating Expenses | $76.1M | $69.9M | $79.8M | ||
| Research & Development | $60.3M | $54.6M | $62.6M | ||
| Research Expense | $60.3M | $54.6M | $62.6M | ||
| Selling, General & Administrative | $15.8M | $15.3M | $17.3M | ||
| General & Administrative Expenses | $15.8M | $15.3M | $17.3M | ||
| Salaries & Wages | $-3.3M | $4.7M | -- | ||
| Depreciation & Amortization | $-566.0K | -- | -- | ||
| Depreciation & Amortization | $-566.0K | -- | -- | ||
| Other Operating Expenses | -- | $36.4M | -- | ||
| OPERATING INCOME | |||||
| Operating income | $-72.2M | $-55.1M | $-52.5M | ||
| EBITDA | $-68.9M | $-51.8M | $-48.6M | ||
| NON-OPERATING ITEMS | |||||
| Interest Expense (Non-Operating) | -- | $176.0K | $133.0K | ||
| Interest Income Operating | -- | $1.5M | $142.0K | ||
| Intinc | $69.0K | $1.0M | $3.2M | ||
| Net Non-Operating Interest Income/Expense | $69.0K | $868.0K | $3.1M | ||
| Other Income/Expense | $-1.3M | $-1.5M | -- | ||
| SPECIAL ITEMS | |||||
| Special Income Charges | $-355.0K | -- | -- | ||
| PRE-TAX INCOME | |||||
| EBIT | $-70.7M | $-54.0M | $-50.8M | ||
| Pre-Tax Income | $-70.7M | $-54.2M | $-50.9M | ||
| INCOME TAX | |||||
| Tax Provision | $13.0K | $10.0K | $3.0K | ||
| NET INCOME | |||||
| Net Income | $-70.7M | $-54.2M | $-50.9M | ||
| Net Income (Continuing Operations) | $-70.7M | $-54.2M | $-50.9M | ||
| Net Income (Discontinued Operations) | $-70.7M | $-54.2M | $-50.9M | ||
| Net Income (Common Stockholders) | $-70.7M | $-54.2M | $-50.9M | ||
| Normalized Income | -- | $-39.9M | $-50.4M | ||
| TOTALS | |||||
| Total Expenses | $1.3M | $69.9M | $79.8M | ||
| SHARE & EPS DATA | |||||
| Average Shares Outstanding | $83.6M | $84.7M | $99.7M | ||
| Average Shares Outstanding (Diluted) | $83.2M | $84.7M | $99.7M | ||
| Shares Outstanding | $83.6M | $100.4M | $100.4M | ||
| Basic EPS | $-0.85 | $-0.64 | $-0.51 | ||
| Basic EPS (Continuing Operations) | -- | $-0.64 | $-0.51 | ||
| Diluted EPS | $-0.85 | $-0.64 | $-0.51 | ||
| Diluted EPS (Continuing Operations) | -- | $-0.64 | $-0.51 | ||
| OTHER METRICS | |||||
| Other Gand A | $15.8M | $15.3M | $17.3M | ||
| Rent And Landing Fees | $15.8M | -- | -- | ||
| Write Off | $355.0K | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACIU | $2.53 | +3.3% | 60.79K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |